Analysts: Sepracor decrease could mean cut in DTC

Share this article:

Sepracor said in reporting Q4 2007 results, 2008 revenues projected to be spent on sales, marketing and distribution expenses would likely decrease around 10% compared with 2007, despite planned launches. Analysts speculated that the decrease could mean a cut in DTC.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.